How Many Chronic Myeloid Leukemia Patients Who Started a Frontline Second‐generation Tyrosine Kinase Inhibitor Have to Switch to a Second‐line Treatment? A Retrospective Analysis From the Monitoring Registries of the Italian Medicines Agency (AIFA)

Cancer Medicine - United Kingdom
doi 10.1002/cam4.3071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
OncologyHematology
2011English

Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
OncologyHematology
2016English

Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy

Blood Cancer Journal
OncologyHematology
2012English

Use of Second- And Third-Generation Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia: An Evolving Treatment Paradigm

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Oncology and Therapy
Oncology
2019English

Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia

Cancer
Cancer ResearchOncology
2010English

Discovering Gene Expression Signatures Responding to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia

BMC Medical Genomics
Genetics
2016English

Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy